1015 Capital Partners’s Insulet PODD Stock Holding History

1015 Capital Partners’s Portfolio PODD Stock Details PODD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-2	Closed	-$420	–	625
2026 Q1	$420	Sell	2 -1	-33%	-$251	﹤0.01%	539
2025 Q4	$853	Buy	+3	New	+$938	﹤0.01%	479

Other funds holding PODD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

1015 Capital Partners's PODD Position: Q2 2026 in Review

1015 Capital Partners sold out of Insulet (PODD) in Q2 2026, closing a stake of 2 shares — an estimated $420 sold.

1015 Capital Partners first reported a position in PODD in Q4 2025 and held it in 2 quarters. The position peaked at $853 in Q4 2025. 720 funds tracked by Wall St. Rank hold PODD as of Q2 2026.

1015 Capital Partners reported no remaining Insulet position as of Q2 2026 after selling out during the quarter.
1015 Capital Partners sold 2 Insulet shares in Q2 2026, an estimated $420.
1015 Capital Partners first reported a position in Insulet in Q4 2025 and held it in 2 quarters.
1015 Capital Partners's Insulet position peaked at $853 in Q4 2025.
720 funds tracked by Wall St. Rank held Insulet as of Q2 2026.

Based on 1015 Capital Partners's 13F filing for Q2 2026, filed 21 Jul 2026.